Method of treating anxiety disorders
AssigneeAstraZeneca AB
InventorsPatricia Davis, Jeffrey Goldstein, Scott Grimm, Helen Winter, Raymond Suckow
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstraZeneca AB
InventorsPatricia Davis, Jeffrey Goldstein, Scott Grimm, Helen Winter, Raymond Suckow
Estimating the term…
A method of treating at least one symptom or condition associated with but not limited to: Anxiety Disorders including but not limited to Panic Disorder Without Agoraphobia, Panic Disorder With Agoraphobia, Agoraphobia Without History of Panic Disorder, Specific Phobia, Social Phobia, Obsessive-Compulsive Disorder, Postaumatic Stress Disorder, Acute Stress Disorder, Generalized Anxiety Disorder and Generalized Anxiety Disorder Due to a General Medical Condition comprising administering an effective amount of Formula I or its pharmaceutically acceptable salt. In another aspect of the invention a pharmaceutical composition is provided comprising an effective amount of Formula I or its pharmaceutically acceptable salt and at least one pharmaceutically acceptable carrier or diluent.
A method of treating at least one symptom or condition associated with an Anxiety Disorder in a human comprising administering to the human an oral pharmaceutical composition comprising 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine or its pharmaceutically acceptable salt in an amount effective to treat the symptom or condition associated with the Anxiety Disorder.
An oral pharmaceutical composition comprising the compound of Formula I:
Dependencies are inferred from the claim text.